Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifampicin plus biliary drainage in obstructive cholestasis
NL-OMON24804Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of rifampicin in Extrahepatic cholestasis (EHC) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Serum bilirubin levels. Started Oct 2012; status: completed.
02
Drugs
rifampicin
03
Conditions
Extrahepatic cholestasis (EHC)
Beyond the preview
Go deeper on NL-OMON24804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24804.